IMAHEP: Hepatic Small Vessel Neoplasm
Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06067035
Collaborator
(none)
20
13
Study Details
Study Description
Brief Summary
Small-vessel hepatic tumor is a new tumor entity of vascular origin, described in 2016 by Gill et al, in a series of 17 patients. This rare lesion is difficult to diagnose on imaging because it shares a common radiological semiology with several other differential diagnoses ranging from benign hepatic angioma to more aggressive lesions such as angiosarcoma.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The aim of our study is to enable the imaging diagnosis of a new entity: small vessel hepatic tumor in order to improve diagnostic management.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
20 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Imaging of Small-vessel Liver Tumours
Anticipated Study Start Date
:
Oct 1, 2023
Anticipated Primary Completion Date
:
Nov 1, 2024
Anticipated Study Completion Date
:
Nov 1, 2024
Outcome Measures
Primary Outcome Measures
- Imaging findings [12 months]
Aspect on US Ultrasound Scan (US)
Secondary Outcome Measures
- Pathological examination [12 months]
tumors
- Biology [12 months]
bilirubin and alkaline phosphatase rate
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Histological evidence of a small vessel hepatic tumor either on biopsy or surgical specimen
-
Cross-sectional imaging before the biopsy or pre-operatively (CT, MRI)
Exclusion Criteria:
- Patient under guardianship or curators
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Assistance Publique - Hôpitaux de Paris
Investigators
- Study Director: MAITE LEWIN, MD, PHD, APHP
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT06067035
Other Study ID Numbers:
- APHP220863
First Posted:
Oct 4, 2023
Last Update Posted:
Oct 4, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms: